Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Chemistry of new immunosuppressive triterpenoid elucidated by Merck & Co.

April 9, 1998

BioTransplant and MedImmune announce patent for MEDI-507 and BTI-322 antibodies

April 7, 1998

Interferon-inducing purines disclosed by Japan Energy

April 7, 1998

Pivotal phase III trial of Nabi-StaphVAX now under way

April 6, 1998

NIH offers malaria vaccine technology for licensing

April 3, 1998

Zenapax launched in Switzerland

March 17, 1998

Immunosuppressive analogues of a natural immunostimulant

March 16, 1998

New malaria vaccine described in patent literature

March 16, 1998

Novel immunomodulatory agents described by Takeda

March 12, 1998

Alliance formed for development of oral vaccines from plants

March 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...